These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 18555944

  • 1. Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Farrar JT, Troxel AB, Stott C, Duncombe P, Jensen MP.
    Clin Ther; 2008 May; 30(5):974-85. PubMed ID: 18555944
    [Abstract] [Full Text] [Related]

  • 2. A pilot study of a comparison between a patient scored numeric rating scale and clinician scored measures of spasticity in multiple sclerosis.
    Anwar K, Barnes MP.
    NeuroRehabilitation; 2009 May; 24(4):333-40. PubMed ID: 19597271
    [Abstract] [Full Text] [Related]

  • 3. A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis.
    Collin C, Ehler E, Waberzinek G, Alsindi Z, Davies P, Powell K, Notcutt W, O'Leary C, Ratcliffe S, Nováková I, Zapletalova O, Piková J, Ambler Z.
    Neurol Res; 2010 Jun; 32(5):451-9. PubMed ID: 20307378
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Worst Itch Numeric Rating Scale for Prurigo Nodularis: A Secondary Analysis of 2 Randomized Clinical Trials.
    Kwatra SG, Yosipovitch G, Kim B, Stander S, Rhoten S, Ivanescu C, Haeusler N, Brookes E, Msihid J, Makhija M, Bansal A, Thomas RB, Bahloul D.
    JAMA Dermatol; 2024 Aug 01; 160(8):813-821. PubMed ID: 38865146
    [Abstract] [Full Text] [Related]

  • 6. Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis.
    Wade DT, Collin C, Stott C, Duncombe P.
    Mult Scler; 2010 Jun 01; 16(6):707-14. PubMed ID: 20558502
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis.
    Novotna A, Mares J, Ratcliffe S, Novakova I, Vachova M, Zapletalova O, Gasperini C, Pozzilli C, Cefaro L, Comi G, Rossi P, Ambler Z, Stelmasiak Z, Erdmann A, Montalban X, Klimek A, Davies P, Sativex Spasticity Study Group.
    Eur J Neurol; 2011 Sep 01; 18(9):1122-31. PubMed ID: 21362108
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
    Bastyr EJ, Price KL, Bril V, MBBQ Study Group.
    Clin Ther; 2005 Aug 01; 27(8):1278-94. PubMed ID: 16199253
    [Abstract] [Full Text] [Related]

  • 10. Psychometric properties of the Neck Disability Index and Numeric Pain Rating Scale in patients with mechanical neck pain.
    Cleland JA, Childs JD, Whitman JM.
    Arch Phys Med Rehabil; 2008 Jan 01; 89(1):69-74. PubMed ID: 18164333
    [Abstract] [Full Text] [Related]

  • 11. Pathophysiology, assessment and management of multiple sclerosis spasticity: an update.
    Haas J.
    Expert Rev Neurother; 2011 Apr 01; 11(4 Suppl):3-8. PubMed ID: 21449853
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Validity and reliability of the Serbian version of Patient-Reported Impact of Spasticity Measure in multiple sclerosis.
    Knezevic T, Konstantinovic L, Rodic S, Foti C, Drulovic J, Dackovic J, Nikolic D, Petronic I, Stokic DS.
    Int J Rehabil Res; 2015 Sep 01; 38(3):199-205. PubMed ID: 25603541
    [Abstract] [Full Text] [Related]

  • 16. Psychometric properties of the Itch Numeric Rating Scale in patients with moderate-to-severe plaque psoriasis.
    Kimball AB, Naegeli AN, Edson-Heredia E, Lin CY, Gaich C, Nikaï E, Wyrwich K, Yosipovitch G.
    Br J Dermatol; 2016 Jul 01; 175(1):157-62. PubMed ID: 26852717
    [Abstract] [Full Text] [Related]

  • 17. A randomized trial of memantine as treatment for spasticity in multiple sclerosis.
    Mehta LR, McDermott MP, Goodman AD, Schwid SR.
    Mult Scler; 2010 Feb 01; 16(2):248-51. PubMed ID: 20028712
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.
    Nicholas J, Lublin F, Klineova S, Berwaerts J, Chinnapongse R, Checketts D, Javaid S, Steinerman JR.
    Mult Scler Relat Disord; 2023 Jul 01; 75():104745. PubMed ID: 37209500
    [Abstract] [Full Text] [Related]

  • 19. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, Scleroderma Clinical Trials Consortium.
    Arthritis Rheum; 2002 Sep 01; 46(9):2410-20. PubMed ID: 12355489
    [Abstract] [Full Text] [Related]

  • 20. Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis.
    Tintoré M.
    Neurodegener Dis Manag; 2015 Sep 01; 5(6 Suppl):15-7. PubMed ID: 26611266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.